{
"@context": "https://schema.org",
"@type": "Article",
"headline": "New Safe Harbor and General Compliance Program Guidance Provides Opportunity for Buyers to Mitigate Litigation and Fraud Risk",
"url": "https://www.lexblog.com/2024/01/30/new-safe-harbor-and-general-compliance-program-guidance-provides-opportunity-for-buyers-to-mitigate-litigation-and-fraud-risk/",
"identifier": {
"@type": "PropertyValue",
"name": "LexBlog Library record",
"value": "LEX-WK-FQFC8F9A",
"url": "https://www.lexblog.com/lib/FQFC8F9A/"
},
"datePublished": "2024-01-30T11:04:43-05:00",
"dateModified": "2024-01-30T10:34:53-05:00",
"author": {
"@type": "Person",
"name": "Martin G. Burkett, Noam Fischman, Danielle C. Gordet"
},
"sourceOrganization": {
"@type": "Organization",
"name": "Akerman LLP"
},
"organizationScope": "at-publication",
"isPartOf": "Health Law Rx",
"about": "Health Care and Life Sciences",
"sourceUrl": "https://www.healthlawrx.com/?p=4113",
"sourceStability": "may-move"
}